Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Atopic Dermatitis Market In 2029?
In recent times, the size of the atopic dermatitis market has expanded significantly. The projection shows an increase from $8.61 billion in 2024 to about $9.88 billion in 2025, which signifies a compound annual growth rate (CAGR) of 14.7%. Factors such as improved medical knowledge and awareness, changes in incidence and prevalence rates, support and advocacy for patients, the evolution of treatment options, and research and development have all contributed to the growth seen in the historic period.
Anticipated to experience a swift expansion in the coming years, the market for atopic dermatitis is predicted to reach a value of $17.08 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 14.7%. This projected rise during the forecast period can be linked to the progress in the fields of biologic therapies, small molecule drugs, immunomodulators as well as treatments specially developed for pediatric use, besides innovative approaches like gene therapy and precision medicine. Other noteworthy trends predicted for the forecast period comprise advancements in topical treatments, a stronger focus on pediatric atopic dermatitis care, strategies for managing environmental factors and allergens, along with the evolution of precise diagnostic tools.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Atopic Dermatitis Market?
The anticipated growth of the atopic dermatitis market is largely driven by the widespread occurrence of the skin condition. Atopic dermatitis or eczema is characterized by skin dryness and itchiness, and the rise in the number of people suffering from this condition necessitates enhanced diagnostic and treatment measures. Oxford Academic, a UK-based publisher, reveals that atopic dermatitis (AD) is globally pervasive, affecting approximately 2.6% of the global population, which translates to an estimated 204 million people in 2024. This statistic which includes roughly 101 million adults and 103 million children signifies the extent to which the prevalence of atopic dermatitis can influence the market growth.
Which Primary Segments of the Atopic Dermatitis Market Are Driving Growth and Industry Transformations?
The atopic dermatitismarket covered in this report is segmented –
1) By Drug Class: Corticosteroids; Emollients Or Moisturizers; IL-4 And PDE4 Inhibitors; Calcineurin Inhibitors; Antibiotics; Other Drug Classes
2) By Mode of Administration: Topical; Injectable; Oral
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Corticosteroids: Topical Corticosteroids; Systemic Corticosteroids
2) By Emollients Or Moisturizers: Creams and Lotions; Ointments and Balms; Barrier Repair Creams
3) By IL-4 And PDE4 Inhibitors: Dupilumab (IL-4 Inhibitor); Apremilast (PDE4 Inhibitor)
4) By Calcineurin Inhibitors: Tacrolimus Ointment; Pimecrolimus Cream
5) By Antibiotics: Topical Antibiotics; Systemic Antibiotics
6) By Other Drug Classes: Antihistamines; Biologics; JAK Inhibitors
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8285&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Atopic Dermatitis Market?# Market?
North America was the largest region in the atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Atopic Dermatitis Market?
The atopic dermatitis market is increasingly characterized by product innovations, a trend that is being championed by leading companies seeking to solidify their stronghold in the industry. For instance, June 2022 saw Regeneron Pharmaceuticals Inc., an American biotechnology corporation, receive FDA approval for Dupixent (dupilumab). This drug is recognized for its effectiveness in treating children aged 6 months to 5 years who are dealing with moderate-to-severe atopic dermatitis. Dupixent can be applied in conjunction with topical corticosteroids or on its own. Its mechanism of action involves suppressing the signaling of two major Type 2 inflammatory triggers (IL-4 and IL-13), which are critical in the manifestation of illnesses such as eosinophilic esophagitis, prurigo nodularis, chronic rhinosinusitis with nasal polyposis, and asthma.
View the full report here:
https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report
What Parameters Are Used to Define the Atopic Dermatitis Market?
Atopic dermatitis is a dermatological condition that causes dryness and itching of the skin. It is a chronic condition that progresses over time and is not spread by contact.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8285
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model